small molecule

CHILDREN'S ALLEGRA ALLERGY

FEXOFENADINE HYDROCHLORIDE

Loss of exclusivityAugust 2030latest FDA-listed patent expiry
CompanyCHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Drug detail

Brand nameCHILDREN'S ALLEGRA ALLERGY
Active ingredientFEXOFENADINE HYDROCHLORIDE
Strength30MG/5ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2011
Marketing statusOTC

Listed patents

PatentExpiresType
8933097August 2030product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.